Report - Company presentation for investors · 21 Investor Presentation FY2014 Compound AR affinity Ki (nM) Antagonism WT AR IC50 (nM) Proliferation VCaP IC50 (nM) enzalutamide 78 155 400

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form